Status:
COMPLETED
Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid
Lead Sponsor:
Oplon-Pure Science Ltd.
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.
Detailed Description
Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.
Eligibility Criteria
Inclusion
- Acne Vulgaris
- Over 18 years
- Signing informed consent
Exclusion
- Active treatment of acne
- Change in hormonal therapy
- Antibiotic treatment in a week prior to the experiment
- Sensitive skin
- Pregnancy
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01179633
Start Date
March 1 2010
End Date
June 1 2010
Last Update
August 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Clinic
Netanya, Israel